Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan T Yang

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Neuro-Oncology|March 5, 2024
Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumorsAndrew B Barbour, Barbara Blouw, Lynne P Taylor, et al.
Advances in Radiation Oncology|September 29, 2021
Should Postoperative Radiation for Long Bone Metastases Cover Part or All of the Orthopedic Hardware? Results of a Large Retrospective AnalysisDaniel B Rosen, Justin M Haseltine, Meredith Bartelstein, et al.
Advances in Radiation Oncology|December 11, 2025
Impact of a Dedicated Inpatient Radiation Oncology Consult Service on Goal-Concordant CareMorgan E Freret, Divya Yerramilli, Victoria S Brennan, et al.
Journal of Applied Clinical Medical Physics|January 2, 2026
Clinical experience with a same-day simulation and treatment program for stereotactic radiation therapy on a C-arm linacMichalis Aristophanous, Sernger Shen, Dylan G Hsu, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Journal of Neuro-Oncology|August 23, 2022
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2021
Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone MetastasesNoah J Mathis, Connor J Doyle, Daniel B Rosen, et al.
INFORMS Journal on Applied Analytics|July 18, 2022
Automated and Clinically Optimal Treatment Planning for Cancer RadiotherapyMasoud Zarepisheh, Linda Hong, Ying Zhou, et al.
Journal of Neuro-Oncology|July 27, 2022
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2026
Preoperative Stereotactic Body Radiotherapy for Metastatic Bone Disease With Impending Fracture: A Nonrandomized Clinical TrialMax Vaynrub, Meredith K Bartelstein, Victoria Y Yu, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|March 5, 2024
Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumorsAndrew B Barbour, Barbara Blouw, Lynne P Taylor, et al.
Advances in Radiation Oncology|September 29, 2021
Should Postoperative Radiation for Long Bone Metastases Cover Part or All of the Orthopedic Hardware? Results of a Large Retrospective AnalysisDaniel B Rosen, Justin M Haseltine, Meredith Bartelstein, et al.
Advances in Radiation Oncology|December 11, 2025
Impact of a Dedicated Inpatient Radiation Oncology Consult Service on Goal-Concordant CareMorgan E Freret, Divya Yerramilli, Victoria S Brennan, et al.
Journal of Applied Clinical Medical Physics|January 2, 2026
Clinical experience with a same-day simulation and treatment program for stereotactic radiation therapy on a C-arm linacMichalis Aristophanous, Sernger Shen, Dylan G Hsu, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Journal of Neuro-Oncology|August 23, 2022
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2021
Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone MetastasesNoah J Mathis, Connor J Doyle, Daniel B Rosen, et al.
INFORMS Journal on Applied Analytics|July 18, 2022
Automated and Clinically Optimal Treatment Planning for Cancer RadiotherapyMasoud Zarepisheh, Linda Hong, Ying Zhou, et al.
Journal of Neuro-Oncology|July 27, 2022
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastasesBrandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2026
Preoperative Stereotactic Body Radiotherapy for Metastatic Bone Disease With Impending Fracture: A Nonrandomized Clinical TrialMax Vaynrub, Meredith K Bartelstein, Victoria Y Yu, et al.
Pageof 6